Literature DB >> 2173850

Inactivated candidate vaccines for hepatitis A.

F E André1, A Hepburn, E D'Hondt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2173850

Source DB:  PubMed          Journal:  Prog Med Virol        ISSN： 0079-645X


× No keyword cloud information.
  12 in total

1.  Hepatitis A.

Authors:  A J Tilzey; J E Banatvala
Journal:  BMJ       Date:  1991-06-29

2.  Immune response to hepatitis A virus capsid proteins after infection.

Authors:  C H Wang; S Y Tschen; U Heinricy; M Weber; B Flehmig
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

3.  New, ultrasensitive enzyme immunoassay for detecting vaccine- and disease-induced hepatitis A virus-specific immunoglobulin G in saliva.

Authors:  J J Ochnio; D W Scheifele; M Ho; L A Mitchell
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

4.  Progress toward the development of a genetically engineered attenuated hepatitis A virus vaccine.

Authors:  A W Funkhouser; G Raychaudhuri; R H Purcell; S Govindarajan; R Elkins; S U Emerson
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 5.  New hepatitis A vaccines and their role in prevention.

Authors:  D B Strader; L B Seeff
Journal:  Drugs       Date:  1996-03       Impact factor: 9.546

6.  Evaluation of inactivated hepatitis A vaccine in Canadians 40 years of age or more.

Authors:  D W Scheifele; G J Bjornson
Journal:  CMAJ       Date:  1993-02-15       Impact factor: 8.262

Review 7.  Vaccination of adults against travel-related infectious diseases, and new developments in vaccines.

Authors:  P C Döller
Journal:  Infection       Date:  1993 Jan-Feb       Impact factor: 3.553

8.  Recombinant hepatitis A virus antigen: improved production and utility in diagnostic immunoassays.

Authors:  F D LaBrecque; D R LaBrecque; D Klinzman; S Perlman; J B Cederna; P L Winokur; J Q Han; J T Stapleton
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

Review 9.  Safety and effectiveness of the new inactivated hepatitis A virus vaccine.

Authors:  J Furesz; D W Scheifele; L Palkonyay
Journal:  CMAJ       Date:  1995-02-01       Impact factor: 8.262

10.  Clinical trial with inactivated hepatitis A vaccine and recommendations for its use.

Authors:  A J Tilzey; S J Palmer; S Barrow; K R Perry; H Tyrrell; A Safary; J E Banatvala
Journal:  BMJ       Date:  1992-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.